Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate

NANot yet recruitingINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Cardiogenic ShockExtracorporeal Membrane Oxygenation ComplicationAcute Respiratory Distress SyndromeInfections
Interventions
DEVICE

Chlorhexidine-impregnated dressings

Sterile adhesive transparent dressings impregnated with Chlorhexidine Gluconate gel applied to ECMO cannulae for up to 7 consecutive days for each dressing, in the absence of exudation or bleeding at the point of insertion and until explantation of the ECMO, sometimes requiring dressing changes.

DEVICE

Non impregnated dressings

Single transparent adhesive dressings not impregnated with Chlorhexidine Gluconate applied to ECMO cannulae for up to 7 consecutive days for each dressing, in the absence of exudation or bleeding at the point of insertion and until explantation of the ECMO, sometimes requiring dressing changes.

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT05750576 - Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate | Biotech Hunter | Biotech Hunter